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Summary
Objective: Study the results of surgical treatment of large vestibular schwannomas.
Material and methods: Between January 1995 and December 2005, 87 stage III and IV unilateral
vestibular schwannomas (Koos classiﬁcation) were operated.
Results: The approach used was for the most part translabyrinthine. Nine patients were oper-
ated in two phases. Tumor exeresis was total in 79% of the cases, nearly total in 17%, and
subtotal in 3.6%. Good facial function was preserved in 63% of the patients. Mortality was zero.
Tumor control after a mean follow-up of 45months was 86%.
Conclusions: Surgery for large vestibular schwannomas should have a 0% mortality rate and
low morbidity. Otoneurosurgical collaboration, with a preference for the translabyrinthine
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Introduction
Vestibular schwannomas can evolve slowly into large tumors.
Symptoms generally begin with strictly otological symptoms
that can be ignored by the patient. Then, as they enlarge,
the tumor reaches the central nervous system, progressively
showing cranial nerve involvement, cerebellar or brainstem
problems, and obstructive internal hydrocephalus. Large
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estibular schwannomas therefore affect the vital progno-
is and their treatment cannot be conservative because
adiotherapy may induce internal hydrencephalus. Surgi-
al removal is therefore the best adapted treatment and
s possible even in the oldest patients because of the low
orbidity of the approaches used.
However, even if the choice of surgery seems easy
o make, it exposes the patient to vital risks, serious
omplications, and functional sequelae that are signif-
cantly greater for large tumors. Surgical management
f patients with large vestibular schwannomas should
herefore provide maximum safety for the patient, in
oth vital and functional terms. Preserving facial motor
unction remains the priority functional consideration,
ow that it is recognized that the chances of pre-
served.
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Figure 1 Koos classiﬁcation. Stage I: tumor conﬁned to inter-
nal auditory canal, diameter 1—10mm; stage II: tumor extension
to external auditory canal, less than 20mm; stage III: tumor
extension to external auditory canal, less than 30mm or touch-
ing the brainstem without causing compression; stage IV: tumor
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mxtension to external auditory canal, greater than 30mm or
ausing brainstem compression (reproduced from Koos et al.
1]).
erving hearing in large vestibular schwannomas are
ow.
atients and methods
f the 1200 tumors of the cerebellopontine angle operated
y the otoneurosurgical team in the past 30 years in our hos-
ital, we have studied the large vestibular schwannomas
reated with ﬁrst-line surgery between January 1995 and
ecember 2005. Stage III and IV tumors according to the Koos
1] morphological classiﬁcation were selected, i.e., those
ouching the brainstem (Fig. 1). This classiﬁcation has the
dvantage of better assessing the relation between tumor
ize and posterior cerebral fossa size. The cases of type II
euroﬁbromatosis were excluded as were all incomplete
linical ﬁles. A total of 87 patients were ﬁnally retained
or this retrospective study. Patient follow-up was closed
n 1 January 2009 so that the last patients included would
ave 3 years of follow-up.
unctional work-up
earing was classiﬁed according to the American Academy of
tolaryngology Head and Neck Surgery (AAO-HNS) guidelines
2]. Classes A and B deﬁne serviceable hearing.
Facial motor function was assessed using the House and
rackmann (HB) classiﬁcation [3]. Good results in facial
otor function correspond to grades 1 and 2.urgical technique
ll patients were operated on by the same otoneurosur-
ical team with systematic intraoperative monitoring of
he facial nerve using a four-channel NIMTM 2.0 (Medtronic)
w
a
n
w
(S. Talfer et al.
nd in certain cases, monitoring of the trigeminal nerve
nd the brainstem with somesthetic evoked potentials. A
obotized microscope-based neuronavigation system (Zeiss
KMTM system and Medtronic’s SurgiscopeTM) was used for
ery large tumors or during certain revisions for evolving
umor residue.
Tumors were excised beginning with hollowing the inte-
ior of the tumor using a Cavitron® ultrasonic aspirator.
hen, the tumor shell was dissected in the subarachnoid
lane so as to leave the facial nerve protected by a thin veil
nd to preserve its vascularization. For the stage IV tumors, a
wo-phase surgical resection strategy was always discussed
ith the patient. Either the surgical strategy was deﬁned
mmediately, aiming to reduce the tumor volume during the
rst phase to remove the compression and edema from the
rainstem, or this decision was made intraoperatively in
ase of dissection problems such as bleeding, adherences,
radycardia, or abnormal somesthetic evoked potentials.
esection was completed in the second phase, in better
onditions.
The quality of tumor resection was evaluated by the
perator according to the description provided by Bloch et
l. [4]. Although eminently subjective, resections were qual-
ﬁed as nearly total if they left only a fragment of the tumor
hell and subtotal if the resection left a larger volume in
lace.
The approaches used were the translabyrinthine,
etrosigmoid, and transotic approaches.
adiographic work-up
he preoperative workup systematically included a CT scan
f the petrous part of the temporal bone and magnetic
esonance imaging (MRI) including T1-weighted sequences
ith and without gadolinium injection and T2-weighted
equences. The tumor volume was calculated on the most
ecent MRIs. All patients had an MRI between 1 and 3months
fter surgery and then annual follow-up during the ﬁrst
years.
tatistical analysis
he qualitative values were compared using the Chi2 test or
he Fisher test of probabilities for small numbers of subjects.
he quantitative variables were compared using the Student
-test. The signiﬁcance threshold was set at 0.05.
esults
he mean age of the 87 patients operated was 50 years
range: 20—77 years). There were 36 stage III tumors and
1 stage IV, with eight giant tumors that extended beyond
he midline (15%).
The time from the ﬁrst clinical signs to diagnosis was a
ean 36months (range, 1—135). Thirty-one patients (36%)
ere diagnosed early (delay < 12months), mainly for stage III
s opposed to stage IV (57% versus 30%; p = 0.040). Late diag-
oses (>5 years) accounted for another 20% of the patients,
ith no signiﬁcant difference between the tumor stages
p = 0.807).
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Table 1 Final facial function in relation to tumor stage (before and after any surgical revision for recurrent tumor).
House and Brackmann
grade
After initial surgery After any surgical revision for recurrence
Number,
stage III
Number,
stage IV
Total Number,
stage III
Number,
stage IV
Total
I 23 (72%) 14 (27%) 37 (45%) 23 (72%) 11 (22%) 34 (41%)
II 4 (13%) 11 (22%) 15 (18%) 4 (13%) 12 (24%) 16 (19%)
III 2 (6%) 10 (20%) 12 (14%) 2 (6%) 10 (20%) 12 (14%)
IV 1 (3%) 10 (20%) 11 (13%) 1 (3%) 10 (20%) 11 (13%)
3 (4%) 1 (3%) 2 (4%) 3 (4%)
5 (6%) 1 (3%) 6 (12%) 7 (8%)
the arachnoid veil left in place or there was a zone in front
of the internal auditory meatus that was difﬁcult to control.
Immediate postoperative facial motor function was ana-
lyzed in 81 patients. Good facial function (grade I or II) was
found in 48% of the patients (n = 39): 70% for stage III tumors
and 33% for stage IV. Of the 42 cases of facial paralysis, we
observed six cases with secondary onset (6.8%) on average
on Day 5. These cases all regressed completely in less than
2months.
The facial result at a later date and at the end of the
initial surgical procedure (in one or two phases), analyzable
in 83 patients, showed 63% good results: 84% for stage III and
49% for stage IV (Table 1). Taking into account the surgical
revisions for recurrent tumors, the ﬁnal result, analyzed at
the last follow-up for each patient and at the end of a mean
follow-up of 45months, was equivalent: 60% good results:
84% for stage III tumors and 45% for stage IV (p = 0.75).
Identiﬁcation of the predictive parameters of the ﬁnal
facial result showed that tumor stage played an impor-
tant role (p = 0.001), as did good immediate facial function
(p < 0.001), tumor hemorrhage (p = 0.043), and whether the
facial nerve could be stimulated at the end of the interven-
tion (p < 0.001). On the other hand, age, sex, the duration
of symptoms, the presence of trigeminal involvement, the
level of hearing impairment, vestibular involvement, and
the quality of the resection had no inﬂuence.
Complications and mortality
Mortality related to the surgery was zero. Twenty patients
(23%) presented potentially severe complications (Table 2),
Table 2 Postoperative complications.
Major complications Number (%)
Cerebrospinal ﬂuid leak 11 (12.6)
Meningitis 3 (2.8)
Hematoma of posterior fossa 1 (1.1)
Ischemic stroke 1 (1.1)
Mixed nerve impairment 4 (4.6)V 1 (3%) 2 (4%)
VI 1 (3%) 4 (8%)
Preoperative symptoms
During the preoperative clinical workup, 93% of the patients
reported hearing impairment, 56% tinnitus, 43% balance
impairment or dizziness, 10% headaches, 7% neuralgia or
facial hypoesthesia.
In 23% of the cases, the clinical examination identiﬁed
a vestibular abnormality, in 7% cerebellar problems, in 13%
hypoesthesia of the trigeminal nerve, in 7% facial paresis.
Five patients had intracranial hypertension, one of whom
also presented contralateral hemiparesis.
These neurological anomalies were ﬁnally present in 26%
of the cases, so that evolved and compressive tumor was sus-
pected based on the clinical examination. All these patients
indeed had a stage IV tumor.
On the functional level, half the patients had serviceable
hearing (51%).
Surgical procedure
The ﬁve patients with a stage IV tumor who presented a dan-
gerous clinical picture with intracranial hypertension were
ﬁrst ﬁtted with a ventriculoperitoneal shunt a mean 12 days
before the intervention. Five other patients presented an
edematous aspect of the brainstem on MRI surrounding the
tumor. They were operated after short-term corticosteroid
therapy. The approaches used were translabyrinthine in
80 cases, retrosigmoid in six cases — for tumors with preser-
vation of serviceable hearing that did not invade the fundus
of the internal auditory canal— and transotic in one case for
a very anterior tumor in the cerebellopontine angle. Nine
stage IV tumors were operated in two phases. The second
surgical phase took place a mean 6months after the ﬁrst
phase (range, 77 days to 17months).
At the end of the surgical procedure (in one or two
phases), resection was total in 69 cases (79%), nearly total
in 15 cases (17%), and subtotal in three cases (3.6%).
Facial functionThe facial nerve was anatomically preserved with certainty
in 83% of the patients (73 patients), partially damaged in
three cases of adherent tumors, and impossible to preserve
in one patient. In 10 cases, the facial nerve was not formally
recognizable along its entire length. It was either masked by
Death, hydrocephalus,
oculomotor impairment,
gaseous embolism
0 (0)
Total 20 (22.9)
6 S. Talfer et al.
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hree of which were particularly serious: a hematoma of
he posterior fossa requiring emergency surgery at the 12th
ostoperative hour, one case of ischemic stroke, and one
ase of severe hypoxemia pneumopathy secondary to swal-
owing impairment after involvement of the mixed nerves.
inally, all these patients were cured with no sequelae.
esidual tumors
ther than the intraoperative evaluation by the surgeon,
umor residues were systematically searched for on post-
perative MRI; 26 residual tumors were identiﬁed and ﬁve
ontrast-enhanced linear images were attributed to inﬂam-
atory tissue or arachnoid folds. During the follow-up, two
ther residual tumor images appeared secondarily at 1 and
years, bringing the total number of residual tumors to
8 (32%). Of the 15 nearly total excisions, in two cases,
o residual tumor was found on imaging. Conversely, of
he 69 total resections, 12 presented an image of a residual
umor (17%).
Of the 28 residual tumors monitored, seven shrank or dis-
ppeared (25%) and nine remained stable for a mean 4-year
ollow-up period (32%). Finally, 12 evolved (43%), becom-
ng a tumor recurrence in 13.8% of the patients in the
eries (86.2% tumor control). These recurrent tumors corre-
ponded to three subtotal resections (100%), six near-total
esections (40%), and three resections evaluated as total
4.3%).
These 12 tumor recurrences required surgery in
0 patients and gamma-knife radiosurgery in another.
he last patient was lost to follow-up after 3 years of
onitoring. The recurrences were reoperated after a mean
elay of 5 years and 5months after the initial excision
range: 2—9.7 years).
One of the patients has not yet achieved complete tumor
ontrol after several interventions. At the age of 20 years,
e presented a very large tumor that was partially resected.
hen, he was lost to follow-up for 9 years. When he was seen
gain, the residual tumor measured 88 cm3. It was progres-
ively reduced in three new interventions over 16months,
hich was hindered by the calciﬁed character of the tumor.
nfortunately, the facial nerve, which had remained func-
ional, was damaged during the last attempt to resect the
arge residue in front of the brainstem (Fig. 2).
iscussion
urgical safety
ll causes combined, mortality rates for vestibular schwan-
oma surgery have dropped substantially over time, with
remendous progress made by surgical teams, and now are
pproximately 1%. Large tumors have a larger surface in
ontact with the brainstem, the cerebellum, and the cra-
ial nerves and blood vessels. They expose the patient to
reater risk. Death results for the most part from hemor-
hagic complications (35% of cases) [5].For these large tumors where the chances of preserving
erviceable hearing are minimal [6], the translabyrinthine
pproach is the choice approach because it provides
aximum safety because of the direct approach to the
erebellopontine angle. This approach can be particularly
t
i
b
wigure 2 Recurrent large vestibular schwannoma before and
fter surgical removal.
seful in cases of cerebellopontine angle hematoma, which
equires emergency revision surgery, in contrast to the
etrolabyrinthine approach, where the cerebellum pushed
ack by the hematoma can become an obstacle. The
ranslabyrinthine approach, which takes longer and is more
elicate, is improved advantageously by otoneurosurgical
ollaboration. In our series, with 0% mortality, rapid sur-
ical revision of the only case of cerebellopontine angle
ematoma saved the patient’s life with no neurological
fter-effects.
tep-by-step exeresis
n our experience, resection of large tumors in several inter-
entions can also reduce operative morbidity. This strategy
as adopted for nine patients (10%). In only three cases,
t was decided during surgery, with a highly hemorrhagic
umor, an adhering tumor, and a case where the dissection
n contact with the brainstem was responsible for severe
radycardia.
During the second intervention, the dissection problems
ere reduced in three cases, identical in four cases, and
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Table 3 Results of facial function during follow-up of stage III and IV vestibular schwannoma surgery.
Authors (year) Number of cases Size % HB grade I and II
Lanmann (1999) [10] 178 > 30mm 52.6
Wu et Sterkers (2000) [11] 40 > 30mm 65
Shin et al. (2000) [12] 30 > 40mm 26
Mamikoglu et al. (2002) [13] 70 > 30mm 45
Yamakani (2004) et al. [14] 50 > 30mm 84
Darrouzet et al. (2004) [9] 239 Koos stage III, IV 44
Deveze et al. (2004) [15] 90 Koos stage III, IV 62
Patni et Kartush (2005) [8] 35 > 30mma 94
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Present series 87
a Maximum transversal diameter including intrameatal portion.
increased in two cases. In ﬁve patients who presented an
edema of the cerebellum, observed initially, the second
surgery was not disturbed by the edema. Comey et al., who
operated 83 large vestibular schwannomas in two or three
phases, showed that sequential resection did not increase
morbidity and made it possible to reduce bleeding and
adherences during the interventions [7]. Patni and Kartush
made the same observations in their series of 34 tumors
[8]. Their technique is very distinctive. It reduces tumor
volume during the ﬁrst intervention via the retrosigmoid
approach without reaming the internal acoustic meatus.
Then, the excision is continued in a second intervention via
the translabyrinthine approach to dissect the facial nerve
in intact tissues in the internal auditory canal. They rec-
ommend undertaking the second phase after 4months so
that the cerebellar edema will have resorbed, and before
6months to prevent tumor progression. They also estimate
that the facial nerve is the most robust during the second
phase and the anatomy of the region nearly the norm. Their
patients found the second phase less disabling.
Facial function
Since mortality in vestibular schwannoma treatment has
become exceptional, preservation of facial nerve functions
has become the priority for patients. Unfortunately, facial
function outcome is less favorable for large tumors [5,9]. It
must be emphasized that even early diagnosis of all vestibu-
lar schwannomas would not prevent the discovery of tumors
that have already evolved, because their symptoms can
appear late. As in 36% of the cases in our series, the tumor
was diagnosed less than 1 year after the beginning of func-
tional warning signs.
Table 3 reports the results from the literature of surgi-
cal series of large vestibular schwannomas [9—16]. A mean
good facial result of 54% (range, 44—94%) was observed. This
discrepancy in the results can be explained by the absence
of uniformity in the deﬁnition of ‘‘large tumor’’ and by the
variability in tumor measurement techniques, which some-
times include the internal auditory canal portion. In our
series, we obtained a good facial function rate, 63%, sim-
T
T
l
w> 40mm 56
Koos stage III, IV 63
lar to the results of other teams, in particular the series
eported by Deveze et al. [15], who also used the Koos tumor
lassiﬁcation. For our patients who presented a recurring
umor, facial function was worsened only slightly by surgi-
al revision of the residue. These revisions involved only
atients initially presenting a stage IV tumor. The rate of
ood facial function decreased from 49 to 45% after surgical
evision during the follow-up period. The search for predic-
ive factors of facial motor function in our study showed the
ighly signiﬁcant inﬂuence of tumor stage as deﬁned by the
oos classiﬁcation (p = 0.001).
A hemorrhagic tumor was also a risk factor for facial
mpairment (64% poor facial function versus 33%; p = 0.043).
ntimely bleeding makes the facial nerve and the arachnoid
lane more difﬁcult to visualize and increases the risk of
echanical (tamponade, aspiration), thermal, or ischemic
esions during coagulation in the immediate vicinity. To
revent injurious dissection of the facial nerve, particu-
arly with adherent tumors, the dissection must occasionally
e interrupted and a small tumor fragment left, particu-
arly with benign tumors, threatening only in their large
ize. In an older patient, a small residue will rarely pose
ubsequent problems. In a young subject, the risk of hav-
ng to return to surgery for tumor recurrence is certainly
reater, but the absence of facial paralysis is a clear advan-
age. Even if our results show no correlation between non
otal resection and a better postoperative facial result
p = 0.475), it is probable that overzealousness in difﬁcult
issections would have worsened the functional result. In
study of 116 vestibular schwannomas larger than 21mm,
eol et al. showed a signiﬁcantly better facial result in cases
f incomplete resection [17]. Many authors prefer conserva-
ive surgery to preserve the nerve structures [8,17]. Analysis
f the literature shows that a mean 23% of stage III and IV
estibular schwannoma removals are incomplete, as in our
tudy (21%) [11—14,8,16,17].umor recurrence
o preserve the nerve structures, removal of large vestibu-
ar schwannomas sometimes leaves a small tumor residue,
hich systematically requires MRI follow-up so that it can be
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bjectively assessed [18]. The distinction between artifact
nd authentic residue is not always simple. Although it is
ecognized that linear images generally correspond to scar
issue or arachnoid folds, only prolonged MRI follow-up can
iagnose residual tumors [19]. As has been observed herein,
t is surprising to ﬁnd no residual tumor images after certain
early total exereses. Three explanations are possible: the
urgeon may have been pessimistic, the follow-up MRI was
ot of sufﬁciently high quality, or small, poorly vascularized
umor residues disappear rapidly. This lack of vascularization
an also explain the involution or the stability of authentic
esidues. We observed that only 43% of the residues evolved.
hese recurrences involved 14% of the patients with a mean
ollow-up of 45months. Their incidence in the literature is
ifﬁcult to evaluate because of the heterogeneity of the
ata, the lack of precision between residual and recurrent
umors, and the short time period between surgery and
adiological follow-up. This follow-up must be prolonged,
hich may run the risk of losing patients to follow-up and
hereby distort the occurrence rate observed. Moreover,
his rate is an important parameter in assessing the facial
unction results. Following up residual tumors in a series
f large vestibular schwannomas over 4 years, Godefroy et
l. observed results that were very similar to ours, with
6% residual tumors and 6% recurrent tumors [20]. Only
he observation of the recurrent tumors is a therapeutic
roblem. Freeman et al. observed 60% evolving residues
21]. Thomassin et al., with a long-term follow-up of 137
atients, observed a peak of tumor recurrence at 8 years.
hey therefore recommend following up patients for at least
years and longer in young patients because of one case of
ecurrence discovered 20 years later [22]. We recommend
ollow-up MRI in the ﬁrst 2months after surgery, then at 1,
, and 5 years, then as needed depending on the presence
f tumor residue. At 10 years, with no residue, it is suitable
o stop follow-up.
Managing recurrences consists either in abstention and
urveillance, possible in elderly subjects, or microsurgical
evision or radiosurgery. Our therapeutic policy has mainly
een surgical. This remedial treatment exposes the patient
gain to risks of neurological sequelae. This risk is classically
igher than during the initial treatment [21,23]; however,
n our series, seven patients out of 10 preserved good facial
unction after surgical revision.
onclusion
reatment of large vestibular schwannomas is surgical, even
f the tumor size is the main risk factor for cranial nerve
esions. In this case, we accept the compromise between
reservation of facial nerve function and at least good
umor control, particularly since revisions have altered this
unction only slightly. This surgery should be performed by
rained surgical teams whose experience guarantees a low
orbidity rate. The mortality rate should tend toward zero
nd all the operative safety measures should be taken to
nsure this outcome. Interventions with a double otoneu-
osurgical team, preferring the translabyrinthine approach
ith excision in several phases if necessary, provides a max-
mum chance of good results in terms of facial function and
n acceptable rate of residual tumor.
[S. Talfer et al.
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